Growth Metrics

Cryo Cell International (CCEL) Change in Accured Expenses (2016 - 2026)

Cryo Cell International's Change in Accured Expenses history spans 17 years, with the latest figure at -$1.4 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$1.4 million for Q1 2026, up 5.59% from a year ago — trailing twelve months through Feb 2026 was -$1.4 million (down 569.97% YoY), and the annual figure for FY2025 was -$1.5 million, down 54926.23%.
  • Change in Accured Expenses for Q1 2026 was -$1.4 million at Cryo Cell International, down from $2.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.4 million in Q4 2023 to a low of -$2.5 million in Q3 2024.
  • The 5-year median for Change in Accured Expenses is -$445135.0 (2023), against an average of -$47597.6.
  • The sharpest move saw Change in Accured Expenses surged 708.73% in 2022, then plummeted 2862.7% in 2023.
  • Year by year, Change in Accured Expenses stood at $1.4 million in 2022, then skyrocketed by 142.47% to $3.4 million in 2023, then decreased by 26.6% to $2.5 million in 2024, then fell by 20.04% to $2.0 million in 2025, then plummeted by 169.76% to -$1.4 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.4 million, $2.0 million, and -$389123.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.